Skip to main content Skip to search Skip to main navigation

PDA: New Publications and Formation of the D/A/CH Chapter

During the press conference of the PDA/FDA Joint Regulatory Conference 2024, PDA (Parenteral Drug Association) announced interesting new publications and the formation of the new D/A/CH Chapter to support local members.

New publications include:

  • Updated Technical Report 68 “Risk-Based Approach for Prevention and Management of Drug Shortages“
    Based on the impact this issue has to the pharmaceutical companies and the patients they supply, PDA provides this updated report free of charge globally.
  • In October the book “Global Sterile Manufacturing – Regulatory Guidance Comparison & Assessment Tools“ will be published.
    The book compares guidances from the FDA, EU, WHO, PIC/S, Canada, China and Japan. It simplyfies the challenging task of looking across regulatory guidances to ensure global compliance. It comes with explanations and Excel® files to work with.

PDA formed the new D/A/CH Chapter. The chapter region consists of Germany, Austria and German-speaking Switzerland. The chapter is led by Richard Denk of SKAN AG, Switzerland.


Source:

PDA Press Conference, 9 September 2024, Washington, DC

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be Interested in the Following Articles:

What is a gas?

What is a gas?

You can view the answer here:
Read more
EMA: Pilot Programme for Breakthrough Devices

EMA: Pilot Programme for Breakthrough Devices

The EMA plans to launch a pilot programme in Q2 2026 to implement the guidance for breakthrough devices issued in December 2025.

Read more
EDQM: New Ph. Eur. Chapter on Data Quality with a Focus on Digital Data

EDQM: New Ph. Eur. Chapter on Data Quality with a Focus on Digital Data

The European Pharmacopoeia (Ph. Eur.) has introduced a new general chapter that provides a framework for managing the quality of data, including digital data, throughout its life cycle.

Read more
PIC/S: Jordan FDA Joins PIC/S

PIC/S: Jordan FDA Joins PIC/S

On 1 January 2026, the Jordan Food & Drug Administration (JFDA) became the 57th PIC/S Participating Authority.

Read more
Swissmedic: Scientific GMDP Meetings

Swissmedic: Scientific GMDP Meetings

Swissmedic offers companies holding or seeking a Swissmedic manufacturing or distribution license the opportunity to discuss project-specific GMP and GDP topics in Scientific GMDP Meetings.

Read more
Purified Water – The new Chinese Pharmacopoeias and What Happens Next?

Purified Water – The new Chinese Pharmacopoeias and What Happens Next?

A new Chinese Pharmacopoeia was published in 2025. This has some significant implications for the pharmaceutical water industry, which we will discuss in more detail in this article. Firstly, it is important to note that cold WFI systems are now permitted worldwide and can be used across the board.
Read more
Previous
Next